Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.50
+1.30 (3.08%)
At close: Sep 5, 2025, 4:00 PM
43.51
+0.01 (0.02%)
After-hours: Sep 5, 2025, 5:38 PM EDT

Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts that cover Kymera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $58.53, which forecasts a 34.55% increase in the stock price over the next year. The lowest target is $44 and the highest is $79.

Price Target: $58.53 (+34.55%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$44$58.53$60$79
Change+1.15%+34.55%+37.93%+81.61%
* Price targets were last updated on Jun 27, 2025.

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy556777
Buy556776
Hold334222
Sell000000
Strong Sell000000
Total131316161615

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Maintains
$56$53
BuyMaintains$56$53+21.84%Jun 27, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$57$53
BuyMaintains$57$53+21.84%Jun 26, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$54$60
Strong BuyMaintains$54$60+37.93%Jun 26, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Upgrades
$38$60
Strong BuyUpgrades$38$60+37.93%Jun 3, 2025
Morgan Stanley
Morgan Stanley
Buy
Upgrades
$49$79
BuyUpgrades$49$79+81.61%Jun 3, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
74.59M
from 47.07M
Increased by 58.45%
Revenue Next Year
57.41M
from 74.59M
Decreased by -23.04%
EPS This Year
-3.48
from -2.98
EPS Next Year
-4.18
from -3.48
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
34.03M72.83M46.83M78.59M47.07M74.59M57.41M
Revenue Growth
1,059.99%114.00%-35.71%67.84%-40.11%58.45%-23.04%
EPS
-3.15-2.09-2.87-2.52-2.98-3.48-4.18
EPS Growth
-------
Forward PE
-------
No. Analysts
-----2222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High154.3M113.7M
Avg74.6M57.4M
Low33.9M13.7M

Revenue Growth

Revenue Growth20252026202720282029
High
227.9%
52.5%
Avg
58.5%
-23.0%
Low
-28.0%
-81.6%

EPS Forecast

EPS20252026202720282029
High-2.60-3.29
Avg-3.48-4.18
Low-3.84-6.20

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.